| Aquinox Pharmaceuticals Nets 2nd Venture Capital Round |
|
|
| Friday, June 18, 2010 5:57:00 AM PDT | VentureDeal Staff |
Vancouver, British Columbia -- Aquinox Pharmaceuticals has landed $25 million in its second round of institutional venture capital investment.
Aquinox is developing small molecule therapeutics targeting "SH2-containing inositol-5-phosphatase for the treatment of inflammatory disease and cancer."
Ventures West led the round, which also included The Pfizer Strategic Investments Group, Johnson & Johnson Development Corporation, Baker Brothers Investments and the BC Advantage Funds. |
|
|
 Email Page |  Print Page |
|
|
|
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
|
 |
|
|
|
 |